Methods Fourteen patients with rheumatoid arthritis were studied during pregnancy and clinical disease activity and serum concentrations of pregnancy associated a2-glycoprotein (PAG) measured at monthly intervals until parturition. Disease activity diminished during pregnancy in 10
Introduction
The beneficial effect of pregnancy on rheumatoid arthritis was first reported by Hench in 1938.1 In one of the few attempts to investigate this very important phenomenon prospectively, Smith and West in 1960 showed that the increased secretion of cortisol which normally occurs during gestation could not account entirely for all the remissions of the disease associated with pregnancy.2 The mechanism of remission of rheumatoid arthritis in pregnancy is still not understood and there is a need for further clinical and laboratory studies. 3 Investigators studying the survival of the fetal allograft are now focusing their attention on non-hormonal pregnancy associated proteins: some of these, like pregnancy associated a2-glycoprotein (PAG) , have immunosuppressive properties in vitro.4 During gestation most normal women produce very high concentrations of PAG (1000-2000 mg/i) but in about a quarter the protein is barely detectable. Similarly, in a recent retrospective analysis Persellin5 found that in a quarter of 274 pregnancies there was no remission of rheumatoid arthritis: he hypothesised that this might have been due to failure of these patients to produce high concentrations of PAG during their pregnancies. We are therefore conducting a multicentre prospective study to determine whether there is a relation between disease activity and serum concentrations of PAG in patients with rheumatoid arthritis during pregnancy. (1), (2), (3), and (4) pregnancies were taken into account the mean PAG concentration in group 1 was found to be 1250 4-737 mg/I, which was significantly higher than the 470 ±304 mg/l in group 2 (p < 0 001). Conversely the mean Camp index in group 1 was significantly lower than that in group 2 (6 5 ±7 4 v 18 7 ± 12 7; p < 0 001). These results suggest an inverse relation between disease activity and serum PAG concentrations, which was confirmed by finding a highly significant (p < 0.001) negative correlation coefficient of -041 when all values from all patients were included in the calculation (fig 2) . No significant differences were found between groups 1 and 2 in the concentrations of SP, (73 4±42-7 mg/l and 66 9±29-6 mg/l respectively) and IgM rheumatoid factor (66 0±77 2 mg/l and 63-8± 47 9 mg/l respectively). There were also no distinguishing features between the groups in age (30 8 ± 5 4 years v 34 ± 1 9 years) or number of previous pregnancies (1-2±0 8 v 1 0±0 7).
Discussion
Preliminary results from this multicentre prospective study indicate that in 10 out of 14 patients rheumatoid disease activity declined during pregnancy. This agrees well with the retrospective analyses of Persellin.5 An appropriate control group of subjects with the disease matched for age and studied over a similar time period would have been desirable to determine whether the incidence of these observed remissions during pregnancy was higher than would be expected from the natural course of the disease. Since all drug treatment would have had to be withheld for eight or nine months, however, this was considered to be impracticable and unethical.
Selecting a method for assessing disease activity was of prime importance for this study. We chose to use the method developed by Camp, which was reported to have low intraobserver and interobserver error. It entailed examining all joints commonly affected in rheumatoid arthritis and scoring for pain on pressure (0-3), pain at rest (O or 1), and synovial swelling (0-3). The Camp index, derived by adding together the individual scores, therefore gives higher values and a more sensitive clinical measure than the more commonly used Ritchie index. It rarely falls to zero, as there is almost always some residual synovial swelling even in joints which have become quiescent. Nevertheless, in three of the 14 patients in our study the Camp index fell to zero during the pregnancy and there was no hesitation in assigning them to the remission group (1). For the remaining patients, however, in whom the patterns of changes in disease activity varied widely, some arbitrary criteria had to be used for assigning them to the remission or non-remission group. We emphasise that these criteria, outlined in Methods, were established by the clinician (AK) early in the study and while unaware of serum PAG concentrations.
No difference was found between the two groups in age, duration of disease, or prepregnancy disease activity state which could be considered to have influenced the course of the disease during the gestation period. All patients stopped their drugs either before or very early in their pregnancies and, except for three patients in the no-remission group (who took non-steroidal anti-inflammatory drugs) they remained without drug treatment until after delivery. There was also no difference between groups 1 and 2 in their prepregnancy drug treatments; five and one of the patients respectively received non-steroidal anti-inflammatory drugs, and four and two respectively were taking second line drugs, while one patient in each group was not receiving any drugs.
In developing the ELISA method for PAG estimations great care was taken to ensure that there would be no interference from IgM rheumatoid factor in some sera by using F(ab')2 fragment of the initial antiserum (see Methods Furthermore, the close association between fall in disease activity and rise in serum PAG concentrations in eight of the 14 patients in this study gives added credence to the highly significant though relatively low negative coefficient between these two variables. It must be emphasised that most clinical methods for assessing disease activity in rheumatoid arthritis are to some extent subjective and can be affected by, for example, variation in the pain threshold of individual patients. Hence to obtain even a low correlation coefficient between a relatively subjective value and a highly accurate measurement of a serum substance is quite remarkable. It is also relevant to draw attention to our finding that there was no correlation between disease activity and another pregnancy associated protein, SP1, which unlike PAG has not been shown to have any immunosuppressive properties in vitro. There may, however, be other factors-for example, hormones and other pregnancy associated proteins not measured so far which could be affecting disease activity in these patients. Nevertheless, the preliminary results of this study provide some evidence for an association between serum PAG concentrations and the course of rheumatoid disease activity during pregnancy.
Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload MARTIN B VAN DER WEYDEN, HUBERT FONG, HATEM H SALEM, ROBERT G BATEY, FRANK J DUDLEY Abstract The erythrocyte ferritin content was measured in patients with either idiopathic haemochromatosis or alcoholic liver disease and iron overload to define its value as a marker for an excess of tissue iron. The mean erythrocyte ferritin content in patients with untreated idiopathic haemochromatosis was increased 60-fold and fell with phlebotomy. After phlebotomy many patients had an increased red cell ferritin content despite normal serum ferritin concentrations. That this reflected persistent iron overload with inadequate phlebotomy was suggested by the higher serum iron concentrations, percentage transferrin saturation, and urinary excretion of iron after administration of desferrioxamine, together with a lower annual iron loss by phlebotomy in this group compared
